These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9873742)

  • 1. Conformationally constrained analogues of diacylglycerol (DAG). 15. The indispensable role of the sn-1 and sn-2 carbonyls in the binding of DAG-lactones to protein kinase C (PK-C).
    Benzaria S; Bienfait B; Nacro K; Wang S; Lewin NE; Beheshti M; Blumberg PM; Marquez VE
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3403-8. PubMed ID: 9873742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained analogues of diacylglycerol (DAG). Effect on protein kinase C (PK-C) binding by the isosteric replacement of sn-1 and sn-2 esters in DAG-lactones.
    Kang JH; Chung HE; Kim SY; Kim Y; Lee J; Lewin NE; Pearce LV; Blumberg PM; Marquez VE
    Bioorg Med Chem; 2003 Jun; 11(12):2529-39. PubMed ID: 12757721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
    Nacro K; Bienfait B; Lee J; Han KC; Kang JH; Benzaria S; Lewin NE; Bhattacharyya DK; Blumberg PM; Marquez VE
    J Med Chem; 2000 Mar; 43(5):921-44. PubMed ID: 10715158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally constrained analogues of diacylglycerol. 20. The search for an elusive binding site on protein kinase C through relocation of the carbonyl pharmacophore along the sn-1 side chain of 1,2-diacylglycerol lactones.
    Tamamura H; Sigano DM; Lewin NE; Blumberg PM; Marquez VE
    J Med Chem; 2004 Jan; 47(3):644-55. PubMed ID: 14736244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained analogues of diacylglycerol (DAG). 17. Contrast between sn-1 and sn-2 DAG lactones in binding to protein kinase C.
    Tamamura H; Bienfait B; Nacro K; Lewin NE; Blumberg PM; Marquez VE
    J Med Chem; 2000 Aug; 43(17):3209-17. PubMed ID: 10966739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrocyclic diacylglycerol-bis-lactones as conformationally constrained analogues of diacylglycerol-lactones. Interactions with protein kinase C.
    Kang JH; Kim SY; Lee J; Marquez VE; Lewin NE; Pearce LV; Blumberg PM
    J Med Chem; 2004 Jul; 47(16):4000-7. PubMed ID: 15267238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally constrained analogues of diacylglycerol. 12. Ultrapotent protein kinase C ligands based on a chiral 4,4-disubstituted heptono-1,4-lactone template.
    Lee J; Sharma R; Wang S; Milne GW; Lewin NE; Szallasi Z; Blumberg PM; George C; Marquez VE
    J Med Chem; 1996 Jan; 39(1):36-45. PubMed ID: 8568825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C.
    Kang JH; Peach ML; Pu Y; Lewin NE; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2005 Sep; 48(18):5738-48. PubMed ID: 16134942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C).
    Tamamura H; Sigano DM; Lewin NE; Peach ML; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2004 Sep; 47(20):4858-64. PubMed ID: 15369389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally constrained analogues of diacylglycerol. 10. Ultrapotent protein kinase C ligands based on a racemic 5-disubstituted tetrahydro-2-furanone template.
    Sharma R; Lee J; Wang S; Milne GW; Lewin NE; Blumberg PM; Marquez VE
    J Med Chem; 1996 Jan; 39(1):19-28. PubMed ID: 8568806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally constrained analogues of diacylglycerol (DAG). 14. Dissection of the roles of the sn-1 and sn-2 carbonyls in DAG mimetics by isopharmacophore replacement.
    Marquez VE; Sharma R; Wang S; Lewin NE; Blumberg PM; Kim IS; Lee J
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1757-62. PubMed ID: 9873429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained analogues of diacylglycerol. 11. Ultrapotent protein kinase C ligands based on a chiral 5-disubstituted tetrahydro-2-furanone template.
    Lee J; Wang S; Milne GW; Sharma R; Lewin NE; Blumberg PM; Marquez VE
    J Med Chem; 1996 Jan; 39(1):29-35. PubMed ID: 8568819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding modes of diacylglycerol (DAG) and DAG lactones to protein kinase C (PK-C).
    Sigano DM; Peach ML; Nacro K; Choi Y; Lewin NE; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2003 Apr; 46(9):1571-9. PubMed ID: 12699375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally constrained analogues of diacylglycerol. 18. The incorporation of a hydroxamate moiety into diacylglycerol-lactones reduces lipophilicity and helps discriminate between sn-1 and sn-2 binding modes to protein kinase C (PK-C). Implications for isozyme specificity.
    Lee J; Han KC; Kang JH; Pearce LL; Lewin NE; Yan S; Benzaria S; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2001 Dec; 44(25):4309-12. PubMed ID: 11728178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions.
    Kang JH; Benzaria S; Sigano DM; Lewin NE; Pu Y; Peach ML; Blumberg PM; Marquez VE
    J Med Chem; 2006 Jun; 49(11):3185-203. PubMed ID: 16722637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally constrained analogues of diacylglycerol (DAG). 28. DAG-dioxolanones reveal a new additional interaction site in the C1b domain of PKC delta.
    Choi Y; Pu Y; Peach ML; Kang JH; Lewin NE; Sigano DM; Garfield SH; Blumberg PM; Marquez VE
    J Med Chem; 2007 Jul; 50(15):3465-81. PubMed ID: 17591763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta2-chimaerin is a novel target for diacylglycerol: binding properties and changes in subcellular localization mediated by ligand binding to its C1 domain.
    Caloca MJ; Garcia-Bermejo ML; Blumberg PM; Lewin NE; Kremmer E; Mischak H; Wang S; Nacro K; Bienfait B; Marquez VE; Kazanietz MG
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11854-9. PubMed ID: 10518540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups.
    Malolanarasimhan K; Kedei N; Sigano DM; Kelley JA; Lai CC; Lewin NE; Surawski RJ; Pavlyukovets VA; Garfield SH; Wincovitch S; Blumberg PM; Marquez VE
    J Med Chem; 2007 Mar; 50(5):962-78. PubMed ID: 17284021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An optimized protein kinase C activating diacylglycerol combining high binding affinity (Ki) with reduced lipophilicity (log P).
    Nacro K; Sigano DM; Yan S; Nicklaus MC; Pearce LL; Lewin NE; Garfield SH; Blumberg PM; Marquez VE
    J Med Chem; 2001 Jun; 44(12):1892-904. PubMed ID: 11384235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C).
    Marquez VE; Blumberg PM
    Acc Chem Res; 2003 Jun; 36(6):434-43. PubMed ID: 12809530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.